

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of plasminogen activation (GO:0010755) | 9.47322024 |
| 2 | homocysteine metabolic process (GO:0050667) | 9.06388717 |
| 3 | folic acid-containing compound biosynthetic process (GO:0009396) | 8.86424087 |
| 4 | desmosome organization (GO:0002934) | 8.09427285 |
| 5 | sulfur amino acid catabolic process (GO:0000098) | 7.29275670 |
| 6 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 7.20898021 |
| 7 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 7.20898021 |
| 8 | cysteine metabolic process (GO:0006534) | 7.02595519 |
| 9 | pteridine-containing compound biosynthetic process (GO:0042559) | 6.72076946 |
| 10 | white fat cell differentiation (GO:0050872) | 6.58006209 |
| 11 | purine nucleotide salvage (GO:0032261) | 6.51881341 |
| 12 | adenosine metabolic process (GO:0046085) | 6.50734312 |
| 13 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 6.01876726 |
| 14 | microtubule nucleation (GO:0007020) | 5.89339116 |
| 15 | negative regulation of keratinocyte proliferation (GO:0010839) | 5.57000054 |
| 16 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 5.53513301 |
| 17 | COPII vesicle coating (GO:0048208) | 5.31017587 |
| 18 | regulation of vitamin D biosynthetic process (GO:0060556) | 5.27082938 |
| 19 | inner ear receptor cell development (GO:0060119) | 5.13106389 |
| 20 | negative regulation of DNA biosynthetic process (GO:2000279) | 5.12587029 |
| 21 | protein-chromophore linkage (GO:0018298) | 5.11896757 |
| 22 | positive regulation of endothelial cell differentiation (GO:0045603) | 4.98191327 |
| 23 | alternative mRNA splicing, via spliceosome (GO:0000380) | 4.94223127 |
| 24 | regulation of gonadotropin secretion (GO:0032276) | 4.86900505 |
| 25 | galactose metabolic process (GO:0006012) | 4.84667798 |
| 26 | tetrahydrofolate metabolic process (GO:0046653) | 4.70562160 |
| 27 | mitochondrial RNA metabolic process (GO:0000959) | 4.56144348 |
| 28 | galactose catabolic process (GO:0019388) | 4.50256207 |
| 29 | response to lipoprotein particle (GO:0055094) | 4.47039295 |
| 30 | folic acid-containing compound metabolic process (GO:0006760) | 4.41284678 |
| 31 | regulation of vitamin metabolic process (GO:0030656) | 4.38284217 |
| 32 | IMP biosynthetic process (GO:0006188) | 4.27183546 |
| 33 | regulation of tight junction assembly (GO:2000810) | 4.23831570 |
| 34 | negative regulation of Ras GTPase activity (GO:0034261) | 4.23333719 |
| 35 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 4.19665766 |
| 36 | cell migration involved in heart development (GO:0060973) | 4.08852344 |
| 37 | peptidyl-proline hydroxylation (GO:0019511) | 4.05757157 |
| 38 | pteridine-containing compound metabolic process (GO:0042558) | 4.05561084 |
| 39 | cartilage morphogenesis (GO:0060536) | 4.03141515 |
| 40 | cochlea development (GO:0090102) | 3.97971714 |
| 41 | rRNA methylation (GO:0031167) | 3.97586479 |
| 42 | L-serine metabolic process (GO:0006563) | 3.95490498 |
| 43 | platelet dense granule organization (GO:0060155) | 3.82122140 |
| 44 | negative regulation of catenin import into nucleus (GO:0035414) | 3.76532834 |
| 45 | acrosome assembly (GO:0001675) | 3.74538811 |
| 46 | primary amino compound metabolic process (GO:1901160) | 3.68780739 |
| 47 | 4-hydroxyproline metabolic process (GO:0019471) | 3.67898523 |
| 48 | negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518) | 3.67548046 |
| 49 | regulation of sequestering of triglyceride (GO:0010889) | 3.66869212 |
| 50 | serine family amino acid biosynthetic process (GO:0009070) | 3.62011881 |
| 51 | negative regulation of acute inflammatory response (GO:0002674) | 3.56465149 |
| 52 | organic cation transport (GO:0015695) | 3.51846961 |
| 53 | protein hydroxylation (GO:0018126) | 3.51623945 |
| 54 | regulation of endothelial cell differentiation (GO:0045601) | 3.49934134 |
| 55 | histone H4-K12 acetylation (GO:0043983) | 3.47674300 |
| 56 | IMP metabolic process (GO:0046040) | 3.47118924 |
| 57 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.44473222 |
| 58 | sulfur amino acid biosynthetic process (GO:0000097) | 3.42969648 |
| 59 | phosphatidylglycerol biosynthetic process (GO:0006655) | 3.39335838 |
| 60 | protein-cofactor linkage (GO:0018065) | 3.32800460 |
| 61 | nucleoside transmembrane transport (GO:1901642) | 3.31768679 |
| 62 | nucleotide salvage (GO:0043173) | 3.24637609 |
| 63 | hepatocyte apoptotic process (GO:0097284) | 3.23187356 |
| 64 | innervation (GO:0060384) | 3.19810174 |
| 65 | response to vitamin A (GO:0033189) | 3.19677420 |
| 66 | activin receptor signaling pathway (GO:0032924) | 3.16802161 |
| 67 | energy homeostasis (GO:0097009) | 3.16648794 |
| 68 | one-carbon metabolic process (GO:0006730) | 3.15233460 |
| 69 | negative regulation of alcohol biosynthetic process (GO:1902931) | 3.13950303 |
| 70 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.13097748 |
| 71 | neural crest cell development (GO:0014032) | 3.11459333 |
| 72 | purine-containing compound salvage (GO:0043101) | 3.09816172 |
| 73 | cellular response to zinc ion (GO:0071294) | 3.07199356 |
| 74 | rRNA modification (GO:0000154) | 3.06160519 |
| 75 | regulation of keratinocyte proliferation (GO:0010837) | 3.05259988 |
| 76 | negative regulation of anoikis (GO:2000811) | 3.02016382 |
| 77 | negative regulation of chondrocyte differentiation (GO:0032331) | 3.00248157 |
| 78 | negative regulation of stem cell proliferation (GO:2000647) | 2.99928129 |
| 79 | glycoside metabolic process (GO:0016137) | 2.99673934 |
| 80 | heme transport (GO:0015886) | 2.98453405 |
| 81 | sulfur amino acid metabolic process (GO:0000096) | 2.97632116 |
| 82 | cardiac epithelial to mesenchymal transition (GO:0060317) | 2.96833200 |
| 83 | photoreceptor cell differentiation (GO:0046530) | 2.96301095 |
| 84 | eye photoreceptor cell differentiation (GO:0001754) | 2.96301095 |
| 85 | folic acid transport (GO:0015884) | 2.94413437 |
| 86 | positive regulation of glycolytic process (GO:0045821) | 2.91909195 |
| 87 | retinol metabolic process (GO:0042572) | 2.89326497 |
| 88 | tRNA modification (GO:0006400) | 2.87802175 |
| 89 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.81090798 |
| 90 | regulation of metalloenzyme activity (GO:0048552) | 2.80545304 |
| 91 | protein targeting to vacuole (GO:0006623) | 2.80027218 |
| 92 | protein targeting to lysosome (GO:0006622) | 2.80027218 |
| 93 | establishment of protein localization to vacuole (GO:0072666) | 2.80027218 |
| 94 | regulation of cholesterol storage (GO:0010885) | 2.78326139 |
| 95 | negative regulation of steroid biosynthetic process (GO:0010894) | 2.77880275 |
| 96 | negative regulation of telomerase activity (GO:0051974) | 2.77556428 |
| 97 | nucleotide-sugar metabolic process (GO:0009225) | 2.77556353 |
| 98 | endocrine pancreas development (GO:0031018) | 2.76382017 |
| 99 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.74146929 |
| 100 | indolalkylamine catabolic process (GO:0046218) | 2.73576886 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 8.56114914 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.18369526 |
| 3 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.83706439 |
| 4 | VDR_22108803_ChIP-Seq_LS180_Human | 2.78749900 |
| 5 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.59354868 |
| 6 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.57003068 |
| 7 | CDX2_22108803_ChIP-Seq_LS180_Human | 2.47707833 |
| 8 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.16508262 |
| 9 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.15162981 |
| 10 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.13091930 |
| 11 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.08438983 |
| 12 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.04092066 |
| 13 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.86196924 |
| 14 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.85021928 |
| 15 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.79649030 |
| 16 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.71149341 |
| 17 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.69829973 |
| 18 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.69025807 |
| 19 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.68907560 |
| 20 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.63675100 |
| 21 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.63416159 |
| 22 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.62964516 |
| 23 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.56546647 |
| 24 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.56515637 |
| 25 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.55086728 |
| 26 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.53492596 |
| 27 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.51753581 |
| 28 | CJUN_26792858_Chip-Seq_BT549_Human | 1.50664899 |
| 29 | FUS_26573619_Chip-Seq_HEK293_Human | 1.50009574 |
| 30 | P300_19829295_ChIP-Seq_ESCs_Human | 1.43592480 |
| 31 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.42564978 |
| 32 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.38777436 |
| 33 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.37925548 |
| 34 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.36850359 |
| 35 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.35909564 |
| 36 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.35370083 |
| 37 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.34642792 |
| 38 | STAT3_23295773_ChIP-Seq_U87_Human | 1.31632193 |
| 39 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.27546334 |
| 40 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.26498373 |
| 41 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.25769367 |
| 42 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.25769367 |
| 43 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.24911601 |
| 44 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.24760413 |
| 45 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.24454596 |
| 46 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.20875933 |
| 47 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.20837851 |
| 48 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.20552417 |
| 49 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.20196101 |
| 50 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.18847100 |
| 51 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.18356967 |
| 52 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.18103004 |
| 53 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.17312899 |
| 54 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.16702398 |
| 55 | NCOR_22424771_ChIP-Seq_293T_Human | 1.16359835 |
| 56 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.16062563 |
| 57 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.15729939 |
| 58 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.15531753 |
| 59 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.15032266 |
| 60 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.14834942 |
| 61 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.14718500 |
| 62 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.13528676 |
| 63 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.13170027 |
| 64 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.12649062 |
| 65 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12269182 |
| 66 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.10342946 |
| 67 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.10301365 |
| 68 | EWS_26573619_Chip-Seq_HEK293_Human | 1.09650153 |
| 69 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.09427154 |
| 70 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.08569288 |
| 71 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.07764491 |
| 72 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.07764491 |
| 73 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.07600628 |
| 74 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.07329829 |
| 75 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.06619429 |
| 76 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05034838 |
| 77 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.04752913 |
| 78 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.04488851 |
| 79 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.04447320 |
| 80 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.04411659 |
| 81 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.04037684 |
| 82 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.03890474 |
| 83 | TP53_16413492_ChIP-PET_HCT116_Human | 1.03076160 |
| 84 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.02926598 |
| 85 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.99303516 |
| 86 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.99258577 |
| 87 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.99181522 |
| 88 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.98848761 |
| 89 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.98759581 |
| 90 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.98743118 |
| 91 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.98661646 |
| 92 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.97811048 |
| 93 | KDM2B_26808549_Chip-Seq_REH_Human | 0.97330302 |
| 94 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.97093115 |
| 95 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.97003220 |
| 96 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.96806586 |
| 97 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.96689983 |
| 98 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.96413106 |
| 99 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.94416790 |
| 100 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.94153959 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.57663225 |
| 2 | MP0005670_abnormal_white_adipose | 4.26096747 |
| 3 | MP0000013_abnormal_adipose_tissue | 4.11515444 |
| 4 | MP0005646_abnormal_pituitary_gland | 3.92022166 |
| 5 | MP0003183_abnormal_peptide_metabolism | 3.61588981 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 3.55447495 |
| 7 | MP0001661_extended_life_span | 3.05785084 |
| 8 | MP0008995_early_reproductive_senescence | 2.91413364 |
| 9 | MP0002938_white_spotting | 2.84255746 |
| 10 | MP0010234_abnormal_vibrissa_follicle | 2.66376931 |
| 11 | MP0000516_abnormal_urinary_system | 2.57270353 |
| 12 | MP0005367_renal/urinary_system_phenotyp | 2.57270353 |
| 13 | MP0003195_calcinosis | 2.52175513 |
| 14 | MP0004885_abnormal_endolymph | 2.46246721 |
| 15 | MP0002138_abnormal_hepatobiliary_system | 2.41957559 |
| 16 | MP0002396_abnormal_hematopoietic_system | 2.37030505 |
| 17 | MP0009780_abnormal_chondrocyte_physiolo | 2.34257545 |
| 18 | MP0003724_increased_susceptibility_to | 2.33233293 |
| 19 | MP0005332_abnormal_amino_acid | 2.23949455 |
| 20 | MP0002139_abnormal_hepatobiliary_system | 2.19069758 |
| 21 | MP0000003_abnormal_adipose_tissue | 2.07093814 |
| 22 | MP0003806_abnormal_nucleotide_metabolis | 2.06698064 |
| 23 | MP0004043_abnormal_pH_regulation | 2.04101349 |
| 24 | MP0004147_increased_porphyrin_level | 2.04072686 |
| 25 | MP0003950_abnormal_plasma_membrane | 1.90851903 |
| 26 | MP0002876_abnormal_thyroid_physiology | 1.74639593 |
| 27 | MP0008872_abnormal_physiological_respon | 1.73327119 |
| 28 | MP0003186_abnormal_redox_activity | 1.70871011 |
| 29 | MP0000371_diluted_coat_color | 1.69432829 |
| 30 | MP0003252_abnormal_bile_duct | 1.63277445 |
| 31 | MP0001944_abnormal_pancreas_morphology | 1.56387509 |
| 32 | MP0000647_abnormal_sebaceous_gland | 1.54999570 |
| 33 | MP0005164_abnormal_response_to | 1.54402408 |
| 34 | MP0002132_abnormal_respiratory_system | 1.53531269 |
| 35 | MP0002095_abnormal_skin_pigmentation | 1.53391068 |
| 36 | MP0001764_abnormal_homeostasis | 1.46943595 |
| 37 | MP0001756_abnormal_urination | 1.45621012 |
| 38 | MP0005085_abnormal_gallbladder_physiolo | 1.44873076 |
| 39 | MP0002736_abnormal_nociception_after | 1.44746199 |
| 40 | MP0003045_fibrosis | 1.44544384 |
| 41 | MP0003786_premature_aging | 1.36059547 |
| 42 | MP0009697_abnormal_copulation | 1.36033096 |
| 43 | MP0002295_abnormal_pulmonary_circulatio | 1.33432257 |
| 44 | MP0005551_abnormal_eye_electrophysiolog | 1.31551587 |
| 45 | MP0004185_abnormal_adipocyte_glucose | 1.30787816 |
| 46 | MP0004019_abnormal_vitamin_homeostasis | 1.27122392 |
| 47 | MP0010678_abnormal_skin_adnexa | 1.26589768 |
| 48 | MP0002163_abnormal_gland_morphology | 1.16617617 |
| 49 | MP0005365_abnormal_bile_salt | 1.08332743 |
| 50 | MP0009643_abnormal_urine_homeostasis | 1.07629494 |
| 51 | MP0005220_abnormal_exocrine_pancreas | 1.07054546 |
| 52 | MP0006054_spinal_hemorrhage | 1.06804604 |
| 53 | MP0002006_tumorigenesis | 1.06336939 |
| 54 | MP0008875_abnormal_xenobiotic_pharmacok | 1.05874016 |
| 55 | MP0001270_distended_abdomen | 1.03435403 |
| 56 | MP0005636_abnormal_mineral_homeostasis | 1.02649973 |
| 57 | MP0000534_abnormal_ureter_morphology | 0.99192218 |
| 58 | MP0005408_hypopigmentation | 0.96755025 |
| 59 | MP0005084_abnormal_gallbladder_morpholo | 0.96277885 |
| 60 | MP0005253_abnormal_eye_physiology | 0.95061745 |
| 61 | MP0001851_eye_inflammation | 0.93186773 |
| 62 | MP0010329_abnormal_lipoprotein_level | 0.89546587 |
| 63 | MP0002078_abnormal_glucose_homeostasis | 0.87585299 |
| 64 | MP0001216_abnormal_epidermal_layer | 0.86320040 |
| 65 | MP0005379_endocrine/exocrine_gland_phen | 0.85443148 |
| 66 | MP0002160_abnormal_reproductive_system | 0.83590875 |
| 67 | MP0002693_abnormal_pancreas_physiology | 0.82753181 |
| 68 | MP0005376_homeostasis/metabolism_phenot | 0.82394133 |
| 69 | MP0000613_abnormal_salivary_gland | 0.81651043 |
| 70 | MP0000762_abnormal_tongue_morphology | 0.78292830 |
| 71 | MP0001666_abnormal_nutrient_absorption | 0.78143032 |
| 72 | MP0002060_abnormal_skin_morphology | 0.77505692 |
| 73 | MP0000538_abnormal_urinary_bladder | 0.73845272 |
| 74 | MP0003011_delayed_dark_adaptation | 0.72468625 |
| 75 | MP0002837_dystrophic_cardiac_calcinosis | 0.71404855 |
| 76 | MP0002168_other_aberrant_phenotype | 0.71324679 |
| 77 | MP0002909_abnormal_adrenal_gland | 0.67876586 |
| 78 | MP0003868_abnormal_feces_composition | 0.67279817 |
| 79 | MP0002166_altered_tumor_susceptibility | 0.64396731 |
| 80 | MP0002075_abnormal_coat/hair_pigmentati | 0.63032290 |
| 81 | MP0001324_abnormal_eye_pigmentation | 0.62773579 |
| 82 | MP0003953_abnormal_hormone_level | 0.60354866 |
| 83 | MP0006072_abnormal_retinal_apoptosis | 0.60261521 |
| 84 | MP0000372_irregular_coat_pigmentation | 0.60054412 |
| 85 | MP0003890_abnormal_embryonic-extraembry | 0.59414241 |
| 86 | MP0004272_abnormal_basement_membrane | 0.58518322 |
| 87 | MP0000367_abnormal_coat/_hair | 0.58335539 |
| 88 | MP0002069_abnormal_eating/drinking_beha | 0.57797069 |
| 89 | MP0002136_abnormal_kidney_physiology | 0.57775465 |
| 90 | MP0002254_reproductive_system_inflammat | 0.57426514 |
| 91 | MP0005410_abnormal_fertilization | 0.55237640 |
| 92 | MP0000631_abnormal_neuroendocrine_gland | 0.53821371 |
| 93 | MP0001186_pigmentation_phenotype | 0.53109913 |
| 94 | MP0004233_abnormal_muscle_weight | 0.52281957 |
| 95 | MP0000627_abnormal_mammary_gland | 0.52257368 |
| 96 | MP0005319_abnormal_enzyme/_coenzyme | 0.52136035 |
| 97 | MP0009115_abnormal_fat_cell | 0.51771321 |
| 98 | MP0003942_abnormal_urinary_system | 0.51187198 |
| 99 | MP0000639_abnormal_adrenal_gland | 0.50607677 |
| 100 | MP0005389_reproductive_system_phenotype | 0.50560535 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 8.32122147 |
| 2 | Abnormality of alanine metabolism (HP:0010916) | 8.32122147 |
| 3 | Hyperalaninemia (HP:0003348) | 8.32122147 |
| 4 | Congenital sensorineural hearing impairment (HP:0008527) | 6.30229069 |
| 5 | Constricted visual fields (HP:0001133) | 5.99804916 |
| 6 | Esophageal varix (HP:0002040) | 5.61376648 |
| 7 | Spontaneous hematomas (HP:0007420) | 4.73760988 |
| 8 | Abnormality of the fetal cardiovascular system (HP:0010948) | 4.70564852 |
| 9 | Abnormal umbilical cord blood vessels (HP:0011403) | 4.70564852 |
| 10 | Single umbilical artery (HP:0001195) | 4.70564852 |
| 11 | White forelock (HP:0002211) | 4.60524413 |
| 12 | Patchy hypopigmentation of hair (HP:0011365) | 4.27265840 |
| 13 | Myocardial infarction (HP:0001658) | 4.14511543 |
| 14 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.99036246 |
| 15 | Abnormality of homocysteine metabolism (HP:0010919) | 3.93419288 |
| 16 | Homocystinuria (HP:0002156) | 3.93419288 |
| 17 | Conjugated hyperbilirubinemia (HP:0002908) | 3.91777648 |
| 18 | Anorexia (HP:0002039) | 3.74342673 |
| 19 | Action tremor (HP:0002345) | 3.63016806 |
| 20 | Conjunctival telangiectasia (HP:0000524) | 3.55499277 |
| 21 | Hypoalphalipoproteinemia (HP:0003233) | 3.24779563 |
| 22 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.19908081 |
| 23 | Abnormality of serum amino acid levels (HP:0003112) | 3.12813504 |
| 24 | Pigmentary retinal degeneration (HP:0001146) | 3.02322728 |
| 25 | Birth length less than 3rd percentile (HP:0003561) | 3.01490159 |
| 26 | Fatigue (HP:0012378) | 2.97874617 |
| 27 | Heterochromia iridis (HP:0001100) | 2.94619972 |
| 28 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.94481456 |
| 29 | Abnormality of the umbilical cord (HP:0010881) | 2.92000570 |
| 30 | Pulmonary embolism (HP:0002204) | 2.91248146 |
| 31 | Poor speech (HP:0002465) | 2.91027700 |
| 32 | Chorioretinal atrophy (HP:0000533) | 2.78333181 |
| 33 | Attenuation of retinal blood vessels (HP:0007843) | 2.73188948 |
| 34 | Visceral angiomatosis (HP:0100761) | 2.71899023 |
| 35 | Generalized aminoaciduria (HP:0002909) | 2.70683655 |
| 36 | Hyperglycemia (HP:0003074) | 2.67123801 |
| 37 | Ileus (HP:0002595) | 2.54887897 |
| 38 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.50771773 |
| 39 | Symptomatic seizures (HP:0011145) | 2.49587609 |
| 40 | Hemangiomatosis (HP:0007461) | 2.43668656 |
| 41 | Epidermoid cyst (HP:0200040) | 2.42395543 |
| 42 | Hypolipoproteinemia (HP:0010981) | 2.42204048 |
| 43 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.41647837 |
| 44 | Toxemia of pregnancy (HP:0100603) | 2.38803369 |
| 45 | Cone-rod dystrophy (HP:0000548) | 2.29853066 |
| 46 | Abnormal tarsal ossification (HP:0008369) | 2.29390295 |
| 47 | Oligomenorrhea (HP:0000876) | 2.28950136 |
| 48 | Hypopigmentation of the fundus (HP:0007894) | 2.27170222 |
| 49 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.27148057 |
| 50 | Cavernous hemangioma (HP:0001048) | 2.26404858 |
| 51 | Thrombophlebitis (HP:0004418) | 2.25506708 |
| 52 | Chronic otitis media (HP:0000389) | 2.22336413 |
| 53 | Postural tremor (HP:0002174) | 2.21445323 |
| 54 | Arteriovenous malformation (HP:0100026) | 2.17770430 |
| 55 | Metaphyseal dysplasia (HP:0100255) | 2.11734377 |
| 56 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.10699238 |
| 57 | Duplicated collecting system (HP:0000081) | 2.08967448 |
| 58 | Proximal tubulopathy (HP:0000114) | 2.07953561 |
| 59 | Portal hypertension (HP:0001409) | 2.07500136 |
| 60 | Disproportionate short-trunk short stature (HP:0003521) | 2.04316434 |
| 61 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.02533078 |
| 62 | Biconcave vertebral bodies (HP:0004586) | 1.99418438 |
| 63 | Increased serum pyruvate (HP:0003542) | 1.95854736 |
| 64 | Cortical visual impairment (HP:0100704) | 1.95632387 |
| 65 | Gingival bleeding (HP:0000225) | 1.94818062 |
| 66 | Megaloblastic anemia (HP:0001889) | 1.94787388 |
| 67 | Abnormality of glycolysis (HP:0004366) | 1.94252896 |
| 68 | Brittle hair (HP:0002299) | 1.93946664 |
| 69 | Abnormality of the renal collecting system (HP:0004742) | 1.93473192 |
| 70 | Maternal diabetes (HP:0009800) | 1.93441411 |
| 71 | Chronic hepatic failure (HP:0100626) | 1.91370581 |
| 72 | Arterial thrombosis (HP:0004420) | 1.91332504 |
| 73 | Abnormality of methionine metabolism (HP:0010901) | 1.90906918 |
| 74 | Vascular calcification (HP:0004934) | 1.89178468 |
| 75 | Pendular nystagmus (HP:0012043) | 1.88958498 |
| 76 | Intrahepatic cholestasis (HP:0001406) | 1.88842760 |
| 77 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.85622044 |
| 78 | Ketoacidosis (HP:0001993) | 1.84899317 |
| 79 | Methylmalonic acidemia (HP:0002912) | 1.84727020 |
| 80 | Abnormality of the hepatic vasculature (HP:0006707) | 1.84419494 |
| 81 | Focal segmental glomerulosclerosis (HP:0000097) | 1.83304831 |
| 82 | Decreased subcutaneous fat (HP:0001002) | 1.82863886 |
| 83 | Increased corneal curvature (HP:0100692) | 1.80855799 |
| 84 | Keratoconus (HP:0000563) | 1.80855799 |
| 85 | Hypomagnesemia (HP:0002917) | 1.80714579 |
| 86 | Hepatocellular carcinoma (HP:0001402) | 1.78283899 |
| 87 | Glucose intolerance (HP:0000833) | 1.77905955 |
| 88 | Tubulointerstitial nephritis (HP:0001970) | 1.76740943 |
| 89 | Nausea (HP:0002018) | 1.74341491 |
| 90 | Chromsome breakage (HP:0040012) | 1.72749514 |
| 91 | Small for gestational age (HP:0001518) | 1.71247250 |
| 92 | Increased purine levels (HP:0004368) | 1.68277407 |
| 93 | Hyperuricemia (HP:0002149) | 1.68277407 |
| 94 | Pustule (HP:0200039) | 1.68253858 |
| 95 | Metabolic acidosis (HP:0001942) | 1.66571050 |
| 96 | Cardiovascular calcification (HP:0011915) | 1.66486604 |
| 97 | Abnormality of subcutaneous fat tissue (HP:0001001) | 1.66168662 |
| 98 | Hyperphosphaturia (HP:0003109) | 1.62112064 |
| 99 | Mucosal telangiectasiae (HP:0100579) | 1.61704059 |
| 100 | Abnormal foot bone ossification (HP:0010675) | 1.57411324 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K3 | 5.31645337 |
| 2 | ACVR1B | 4.59721369 |
| 3 | FRK | 4.17639516 |
| 4 | MAP2K3 | 3.52981843 |
| 5 | FGR | 3.00385146 |
| 6 | LMTK2 | 2.88473045 |
| 7 | MST4 | 2.69072564 |
| 8 | JAK3 | 2.66317339 |
| 9 | CDK9 | 2.58069236 |
| 10 | EIF2AK3 | 2.40051013 |
| 11 | RPS6KB2 | 2.17969889 |
| 12 | SGK223 | 2.07519580 |
| 13 | SGK494 | 2.07519580 |
| 14 | SGK2 | 1.95170340 |
| 15 | MST1R | 1.94748796 |
| 16 | FGFR2 | 1.73703742 |
| 17 | SGK3 | 1.68364662 |
| 18 | EIF2AK1 | 1.64444349 |
| 19 | EPHB2 | 1.63174558 |
| 20 | CCNB1 | 1.57104934 |
| 21 | STK39 | 1.56873835 |
| 22 | NTRK3 | 1.44230440 |
| 23 | NTRK2 | 1.43255133 |
| 24 | MAP4K2 | 1.41913724 |
| 25 | ADRBK1 | 1.33407623 |
| 26 | STK3 | 1.29972903 |
| 27 | FLT3 | 1.26131047 |
| 28 | TRIM28 | 1.24216487 |
| 29 | PKN2 | 1.21923581 |
| 30 | BRSK2 | 1.21181698 |
| 31 | STK24 | 1.17320702 |
| 32 | BMPR1B | 1.16494968 |
| 33 | FGFR3 | 1.14837875 |
| 34 | MAP2K1 | 1.10618370 |
| 35 | GRK1 | 1.10492715 |
| 36 | PRKCE | 1.06023458 |
| 37 | PLK2 | 1.03197488 |
| 38 | TAF1 | 1.02817765 |
| 39 | TRPM7 | 0.99938457 |
| 40 | MAP3K12 | 0.97730795 |
| 41 | EPHA2 | 0.96305318 |
| 42 | STK10 | 0.95289428 |
| 43 | MAP3K2 | 0.94592783 |
| 44 | NUAK1 | 0.89386540 |
| 45 | PAK4 | 0.88098713 |
| 46 | STK38L | 0.88053289 |
| 47 | NEK6 | 0.87290624 |
| 48 | ERBB3 | 0.85526067 |
| 49 | PRKCI | 0.85060618 |
| 50 | INSRR | 0.81611265 |
| 51 | ADRBK2 | 0.81372109 |
| 52 | FGFR1 | 0.80686784 |
| 53 | CSNK1A1 | 0.79602603 |
| 54 | AKT3 | 0.78118219 |
| 55 | WNK4 | 0.76853253 |
| 56 | OXSR1 | 0.76845530 |
| 57 | WNK3 | 0.74006696 |
| 58 | MET | 0.73505603 |
| 59 | YES1 | 0.72257907 |
| 60 | FER | 0.69970831 |
| 61 | PLK3 | 0.68162160 |
| 62 | PTK2 | 0.65771653 |
| 63 | CAMK2D | 0.64945674 |
| 64 | SIK3 | 0.62022541 |
| 65 | BCR | 0.61479289 |
| 66 | MAP3K9 | 0.61021958 |
| 67 | RPS6KB1 | 0.57301905 |
| 68 | TNIK | 0.55974079 |
| 69 | NLK | 0.52506060 |
| 70 | IRAK3 | 0.52070131 |
| 71 | PHKG1 | 0.51695898 |
| 72 | PHKG2 | 0.51695898 |
| 73 | MKNK2 | 0.50387087 |
| 74 | EIF2AK2 | 0.49486661 |
| 75 | TGFBR2 | 0.48557886 |
| 76 | HIPK2 | 0.48372276 |
| 77 | SGK1 | 0.47021496 |
| 78 | PAK3 | 0.46952825 |
| 79 | IKBKB | 0.46900693 |
| 80 | PRKG2 | 0.44199540 |
| 81 | PRKCQ | 0.43987320 |
| 82 | GSK3A | 0.43794121 |
| 83 | PTK2B | 0.43568117 |
| 84 | EGFR | 0.41441593 |
| 85 | INSR | 0.33767226 |
| 86 | BRSK1 | 0.33267610 |
| 87 | WEE1 | 0.32841384 |
| 88 | PTK6 | 0.32747114 |
| 89 | PIK3CA | 0.32625334 |
| 90 | PRKAA2 | 0.31659760 |
| 91 | NEK1 | 0.28040533 |
| 92 | PRKCD | 0.27067953 |
| 93 | ERBB4 | 0.26938551 |
| 94 | PRKAA1 | 0.25447681 |
| 95 | MAPKAPK3 | 0.23837020 |
| 96 | PRKCA | 0.22799798 |
| 97 | JAK2 | 0.20763114 |
| 98 | MELK | 0.20095018 |
| 99 | ABL1 | 0.20093760 |
| 100 | CSNK1G1 | 0.18353993 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.83902477 |
| 2 | Sulfur metabolism_Homo sapiens_hsa00920 | 4.76276398 |
| 3 | One carbon pool by folate_Homo sapiens_hsa00670 | 4.73424338 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.60594908 |
| 5 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.16937239 |
| 6 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.80728271 |
| 7 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 2.63627024 |
| 8 | Galactose metabolism_Homo sapiens_hsa00052 | 2.43074749 |
| 9 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.14304794 |
| 10 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.12568203 |
| 11 | Protein export_Homo sapiens_hsa03060 | 1.99708338 |
| 12 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.87028480 |
| 13 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.82662459 |
| 14 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.64547358 |
| 15 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.63929129 |
| 16 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.61012131 |
| 17 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.50315186 |
| 18 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.49680935 |
| 19 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.48438463 |
| 20 | Other glycan degradation_Homo sapiens_hsa00511 | 1.46509954 |
| 21 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.42016468 |
| 22 | Sulfur relay system_Homo sapiens_hsa04122 | 1.40321358 |
| 23 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.39379224 |
| 24 | GABAergic synapse_Homo sapiens_hsa04727 | 1.34679109 |
| 25 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.33432986 |
| 26 | Retinol metabolism_Homo sapiens_hsa00830 | 1.30441779 |
| 27 | Mineral absorption_Homo sapiens_hsa04978 | 1.17700959 |
| 28 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.16348425 |
| 29 | Morphine addiction_Homo sapiens_hsa05032 | 1.16273828 |
| 30 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.11696439 |
| 31 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.09184434 |
| 32 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.08852600 |
| 33 | Proteasome_Homo sapiens_hsa03050 | 1.05384662 |
| 34 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.04779414 |
| 35 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.99761004 |
| 36 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.98113065 |
| 37 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.97100149 |
| 38 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.95321796 |
| 39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.94473448 |
| 40 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.93732568 |
| 41 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.92221089 |
| 42 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.89934400 |
| 43 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.89896601 |
| 44 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.89811361 |
| 45 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.89441144 |
| 46 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.89026158 |
| 47 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.84928745 |
| 48 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.84430385 |
| 49 | ABC transporters_Homo sapiens_hsa02010 | 0.82012518 |
| 50 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.80622961 |
| 51 | Peroxisome_Homo sapiens_hsa04146 | 0.78581461 |
| 52 | RNA degradation_Homo sapiens_hsa03018 | 0.77726773 |
| 53 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.75108401 |
| 54 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.74280250 |
| 55 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.74158666 |
| 56 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.73749930 |
| 57 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.70998164 |
| 58 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.69933776 |
| 59 | Basal transcription factors_Homo sapiens_hsa03022 | 0.69006542 |
| 60 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.67244796 |
| 61 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.66687122 |
| 62 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.66428903 |
| 63 | Nicotine addiction_Homo sapiens_hsa05033 | 0.66291446 |
| 64 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.65419359 |
| 65 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.65126081 |
| 66 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.62213110 |
| 67 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.61441648 |
| 68 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.60581033 |
| 69 | Metabolic pathways_Homo sapiens_hsa01100 | 0.57309695 |
| 70 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.55238541 |
| 71 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.55114717 |
| 72 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.53622528 |
| 73 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.50169329 |
| 74 | Thyroid cancer_Homo sapiens_hsa05216 | 0.47703647 |
| 75 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.47361375 |
| 76 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.44620458 |
| 77 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.41210787 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.40410838 |
| 79 | Legionellosis_Homo sapiens_hsa05134 | 0.40315752 |
| 80 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.39870773 |
| 81 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.39713212 |
| 82 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.37586264 |
| 83 | Circadian rhythm_Homo sapiens_hsa04710 | 0.37164982 |
| 84 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.34632510 |
| 85 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.34328341 |
| 86 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.31865468 |
| 87 | Homologous recombination_Homo sapiens_hsa03440 | 0.30864386 |
| 88 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.30625835 |
| 89 | Circadian entrainment_Homo sapiens_hsa04713 | 0.28745539 |
| 90 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.28403638 |
| 91 | Adherens junction_Homo sapiens_hsa04520 | 0.26401888 |
| 92 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.23661563 |
| 93 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.22944827 |
| 94 | Taste transduction_Homo sapiens_hsa04742 | 0.21750931 |
| 95 | Pertussis_Homo sapiens_hsa05133 | 0.21133549 |
| 96 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.19845452 |
| 97 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.18286534 |
| 98 | Carbon metabolism_Homo sapiens_hsa01200 | 0.16920288 |
| 99 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.16793416 |
| 100 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.16576074 |

